2009•Clinical Lymphoma & MyelomaRequires access

A159 Safety and Efficacy of Bortezomib in Refractory/Relapsed Multiple Myeloma

CE Lalagianni, Nikolaos Neokleous, C. Vadikoliou, Apostolia Papalexandri, Christos Apostolou, Riant Saloum, Αchilles Anagnostopoulos, Athanasios Fassas

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Bortezomib, Multiple myeloma, Refractory (planetary science), Medicine, Oncology, Internal medicine, Biology, Astrobiology

Back to paper search Browse research topics Original source

A159 Safety and Efficacy of Bortezomib in Refractory/Relapsed Multiple Myeloma — Research Paper | ScholarLens